FMO5 and chronic granulomatous disease: Inactivating mutations in NADPH oxidase result in chronic granulomatous disease (CGD), which is characterized by recurrent bacterial and fungal infections, as well as granulomas that result from the neutrophils’ inability to completely kill and eliminate pathogens (124).